Urine Metabolomic Signature of Distal Diuretics in CKD

MIXED-EFFECTS ANOVA - The urine metabolomic signature of distal diuretics contains metabolomic data from a study assessing the urinary metabolomic fingerprint of treatment with amiloride and hydrochlorothiazide in individuals with chronic kidney disease (CKD) stage G3-G4. The dataset likely contains measurements related to electrolyte balance, ammoniagenesis, and oxidative stress signatures, particularly for patients who developed diuretic-induced hyponatremia. It is intended to highlight the interplay between electrolyte and fluid balance and metabolic adaptations in CKD patients treated with distal diuretics.

Use Cases

• Identifying metabolomic signatures of enhanced ammoniagenesis in CKD patients on diuretics.
• Investigating urinary biomarkers associated with diuretic-induced hyponatremia and oxidative stress.
• Analyzing the interplay between electrolyte balance and metabolic adaptations using mixed-effects ANOVA models.

Strengths

• Dataset is openly licensed under CC-BY-4.0, facilitating reuse and redistribution.
• Focus on a specific clinical population (CKD stage G3-G4) and intervention (distal diuretics) provides clear context.

Limitations

• Column names and a precise row count are not provided, limiting understanding of the data structure.
• Metadata completeness is low, with no information on the organization, specific measurement variables, or sample size.
• The dataset size of 195,545 units is reported, but its meaning (e.g., cells, data points) is ambiguous without context.

Provenance

Source

Crissy Rudolphi

Collection Method

Clinical study assessing urinary metabolomic fingerprint in CKD patients treated with amiloride and hydrochlorothiazide.

Freshness

Last updated on 2026-03-18.